Pilot corpus: NIH-funded biomedical datasets. Any DOI can be scored on demand — network effects sharpen as coverage grows.

Severe Acute Respiratory Syndrome Coronavirus 2 Immunology and Coronavirus Disease 2019 Clinical Outcomes

Infectious Disease Clinics of North America(2025)10.1016/j.idc.2025.02.001Source: DataRank Database

Severe Acute Respiratory Syndrome Coronavirus 2 Immunology and Coronavirus Disease 2019 Clinical Outcomes is a research paper published in Infectious Disease Clinics of North America (2025). On theSindex it has a DataRank of 0.

N/A

0DataRank · unranked

Scored on demand from live citation data

0 citations

Free full text

Cite:

DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?

›Methodology & internals

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Pipeline:MetadataData-paper checkEnrichmentCitation networkScoring

Enrichment:Funding (8 grants)Impact (FWCI 0.00)OA: closedTopics (37)IDs (PubMed, OpenAlex)SDGs (1)

FAIR Checklist

Context only (not used in score)

Findable (1/2)

Has DOI

Accessible (0/2)

Interoperable (0/2)

Reusable (0/3)

FAIR checklist signals are shown for context only and do not affect DataRank scoring.

Run a calibrated FAIR evaluation for this paper →

We only score data papers we can read in full — never from an abstract alone.

Authors (3)

Hsinyen Huang ORCID,Gaurav D. Gaiha ORCID,Aljawharah Alrubayyi ORCID

Live enrichment

PubMed:40089444 OpenAlex:https://openalex.org/W4408437869

National Institutes of Health

Grant: UM1AI144462

National Institutes of Health

Grant: DP2AI154421

National Institutes of Health

Grant: DP1DA058476

National Institutes of Health

Grant: R01AI176533

National Institutes of Health

Grant: UM1AI164560

MASSACHUSETTS GENERAL HOSPITAL

Bill & Melinda Gates Foundation

Burroughs Wellcome Fund

FWCI

0.00

Citation Percentile

0.1%

closedLicense: https://doi.org/10.15223/policy-004

publisherhttps://api.elsevier.com/content/article/PII:S0891552025000066?httpAccept=text/xml

publisherhttps://api.elsevier.com/content/article/PII:S0891552025000066?httpAccept=text/plain

journalhttps://doi.org/10.1016/j.idc.2025.02.001

repositoryhttps://pubmed.ncbi.nlm.nih.gov/40089444

Fields of Study

SARS-CoV-2 and COVID-19 ResearchCOVID-19 Clinical Research StudiesCOVID-19 epidemiological studiesHumansCOVID-19SARS-CoV-2Immunity, CellularCD8-Positive T-LymphocytesImmunity, HumoralCOVID-19 VaccinesAntibodies, Viral

MeSH Terms

COVID-19SARS-CoV-2COVID-19 VaccinesAntibodies, ViralHumansImmunity, CellularCD8-Positive T-LymphocytesImmunity, Humoral

Keywords

MedicineCoronavirusCoronavirus disease 2019 (COVID-19)Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)2019-20 coronavirus outbreakRespiratory systemImmunologyBetacoronavirusVirologyDiseaseIntensive care medicineInfectious disease (medical specialty)Internal medicineOutbreakCell immunityClinical OutcomesCovid-19Sars-cov-2

Sustainable Development Goals

SDG 0: Good health and well-being

Severe Acute Respiratory Syndrome Coronavirus 2 Immunology and Coronavirus Disease 2019 Clinical Outcomes

FAIR Checklist

Authors (3)

Funding (8 grants)

Impact

Open Access

Topics